ArticleBlood cancer journal2022

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.

Keith W Pratz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.